Capricor Therapeutics Profit Margin 2006-2018 | CAPR
Current and historical gross margin, operating margin and net profit margin for Capricor Therapeutics (CAPR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Capricor Therapeutics net profit margin as of September 30, 2018 is 24.75%.
|Capricor Therapeutics Annual Profit Margins
|Capricor Therapeutics Quarterly Profit Margins
||Medical Products Manufacturing
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.